Perforomist (formoterol fumarate dihydrate) NDC 49502-605

NDC codes

FDA NDC Directory

Product NDC (as listed)49502-605Labeler and product segments. Claims need a package NDC.

Product NDC at billing width49502-0605Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
49502-605-30	49502060530	30 POUCH in 1 CARTON (49502-605-30) / 1 VIAL in 1 POUCH / 2 mL in 1 VIALMarketed from Oct 1, 2007
49502-605-61	49502060561	60 POUCH in 1 CARTON (49502-605-61) / 1 VIAL in 1 POUCH (49502-605-95) / 2 mL in 1 VIALMarketed from Oct 1, 2007

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Perforomist
Generic name (nonproprietary): formoterol fumarate dihydrate
Active ingredients: Formoterol fumarate — 20 ug/2mL
Dosage form: Solution
Route: Respiratory (Inhalation)
Labeler: Viatris Specialty LLC
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 022007
Marketing start: Oct 1, 2007
Listing expires: Dec 31, 2026
Other FDA classes: Adrenergic beta2-Agonists (Mechanism)
Identifiers: Product ID 49502-605_4607ec7c-6203-4e4b-877f-c6cb03c15590SPL ID 4607ec7c-6203-4e4b-877f-c6cb03c15590SPL set ID fb2fe258-fe2e-47f6-8adf-ca75bf6f90afRxCUI 1246319, 1246321UNII W34SHF8J2K
Pharmacologic class: beta2-Adrenergic Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N449502060530 followed by a unit qualifier and the quantity

Package 49502-0605-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 31, 2019.

Indications (excerpt from the label)

PERFOROMIST Inhalation Solution is a long-acting beta 2 -adrenergic agonist (beta 2 -agonist) indicated for: • Long-term, twice daily (morning and evening) administration in the maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. ( 1.1 ) Important limitations of use: • PERFOROMIST Inhalation Solution is not indicated to treat acute deteriorations of chronic obstructive pulmonary disease. ( 1.2 , 5.2 ) • PERFOROMIST Inhalation Solution is not indicated to treat asthma. ( 1.2 ) 1.1 Maintenance Treatment of COPD PERFOROMIST (formoterol fumarate) Inhalation Solution is indicated for the long-term,…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 022007

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 022007
Product	Strength	Form · route	Labeler	Product NDC
Formoterol Fumarateformoterol fumarate dihydrate	Formoterol fumarate 20 ug/2mL	SolutionRespiratory (Inhalation)	Mylan Pharmaceuticals Inc.	0378-1631